How the bill that ended the shutdown could threaten the U.S. hemp industry’s future

Key Concepts

• Hemp vs. Marijuana: Both are derived from Cannabis sativa but differ in THC content and federal regulation.
• THC (Delta-9): The primary psychoactive compound in marijuana, responsible for the "high."
• Delta-8 THC: A psychoactive compound derived from hemp, which has gained popularity due to less stringent regulation.
• 2018 Farm Bill: Legalized hemp at the federal level, inadvertently creating a market for hemp-derived psychoactive products.
• FDA Regulation: Lack of FDA oversight on hemp-derived psychoactive products, leading to concerns about safety and product content.
• Hemp Industry Growth: Significant economic impact, including sales figures and benefits for farmers.
• Federal Ban: Recent legislation banning intoxicating hemp products, with potential implications for the industry and state-level regulations.

Legislative Action and Definitions

The recent legislation passed by Congress to reopen the government includes a provision that bans intoxicating products derived from the hemp plant. Hemp is a type of cannabis, similar to marijuana, but is characterized by its low level of the psychoactive compound THC. This lower THC content has historically led to less strict regulation compared to marijuana.

Distinction between Hemp and Marijuana:

• Marijuana/Weed: Federally illegal and contains Delta-9 THC, the primary psychoactive ingredient.
• Hemp: Derived from the same Cannabis sativa plant but contains very low levels of Delta-9 THC. It was legalized under the 2018 Farm Bill. However, hemp can contain other psychoactive compounds, such as Delta-8 THC and THCA.

The "Loophole" and Regulatory Concerns

The legalization of hemp under the 2018 Farm Bill inadvertently created a market for Delta-8 and other psychoactive products derived from hemp. A significant concern raised by critics is that these hemp-derived psychoactive products are not regulated by the FDA. This lack of oversight means that the exact ingredients and potential contaminants in products like Delta-8 gummies or drinks are unknown.

Arguments for Regulation:

• Unknown Ingredients: The absence of FDA regulation means there's no guarantee of what chemicals or additives are present in these products.
• Inconsistent Testing: Products are not always rigorously tested, leading to potential safety issues.
• Adverse Effects: Reports of adverse effects, such as dizziness and nausea, have been linked to these products, although significant fatalities directly attributed to Delta-8 products are not widely reported.

Growth of the Hemp Industry

The hemp industry has experienced substantial growth since the inclusion of hemp legalization in the 2018 Farm Bill.

Economic Impact:

• In 2023, sales of hemp-derived psychoactive products reached approximately $2.7 billion.
• The CBD market, which is not psychoactive but is popular for uses like insomnia and anxiety relief, also contributes to the industry's growth.
• Hemp has provided a new crop for farmers, with states like Kentucky being significant producers.
• These hemp-derived products tend to be most successful in states where cannabis is not yet legal.

Implications of the New Ban

The recent ban on intoxicating hemp products is expected to have significant repercussions.

Potential Dynamics:

• State-Level Regulations: Many states already have their own regulations concerning hemp, similar to their approaches to legal cannabis. The federal ban may create a complex patchwork of regulations across the country.
• Opportunity for Federal Regulation: Despite the ban, the hemp industry may view this as an opportunity to advocate for federal legislation that properly regulates psychoactive hemp products.
• Alternative Approaches: Some opponents of the ban suggest that focusing on "weeding out bad actors" and increasing enforcement, rather than an outright ban, would be a more effective approach.
• FDA Intervention: An argument exists that the FDA could directly regulate the existing hemp industry and its products, though the "loophole" nature of its creation within the Farm Bill might present challenges.

Impact on Existing Products and Business

The fate of THC products derived from hemp currently available on shelves and in establishments like breweries will depend on state laws.

Challenges:

• Interstate Commerce: The federal ban will make it significantly harder for businesses to conduct transactions across state lines.
• Banking Issues: Federal illegality can create substantial challenges for banking services for businesses operating in this sector.

Conclusion

The recent legislative action banning intoxicating hemp products marks a significant shift in the regulation of cannabis derivatives. While the 2018 Farm Bill inadvertently fostered a booming industry for hemp-derived psychoactive compounds like Delta-8 THC, concerns over a lack of FDA oversight and potential safety issues have led to this ban. The ban is expected to create a complex regulatory landscape, impacting interstate commerce and potentially pushing the industry to advocate for clearer federal guidelines. The economic contributions of the hemp industry, including its role in agriculture and the CBD market, are substantial, and the long-term effects of this legislation on its future remain to be seen.